Glanbia shares hit two-year high on back of positive Q1
The global nutrition company predicted continuing solid growth after strong cashflow cut its net debt by a third
Shares in Glanbia reached €13.40 last week, the highest level in almost two years.
The bounce from a starting price of €12.50 last week came on Thursday after the global nutrition company announced a first quarter trading update in which it reinstated its profit outlook for this year.
Glanbia is now guiding earnings per share growth of 6 to 12 per cent for 2021 and has reported improved trading conditions in key markets. It also...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Induction Healthcare in €30 million Australian medtech deal
The move will significantly strengthen the market position of British firm Induction Healthcare, in which the businessman is a key shareholder
Post-surgery bra maker raises half a million from US university
Irish bamboo underwear producer Theya Healthcare will use the latest funding to accelerate its expansion in the US and elsewhere